12 matches for your search in the start-up spotlight
rss
En Carta Diagnostics is a deeptech start-up developing rapid Point-of-Care molecular diagnostics kits. It focuses on the early diagnosis of Lyme disease as a first application. The company operates a patented molecular diagnostics platform with an exclusive worldwide license. Founded in 2022, En ...
Cure51 is a French 'TechBio' company founded by Nicolas Wolikow and Simon Istolainen, alongside seasoned entrepreneurs and five world-renowned oncology centers: Gustave Roussy Institute (IGR, Paris - France), Leon Bérard Center (CLB, Lyon - France), Charité Universitätsmedizin (Berlin - Germany), ...
Eligo Bioscience is the world leader in microbiome in-vivo gene editing and is advancing a highly differentiated pipeline of precision medicines to address unmet medical needs in immunoinflammation, oncology, and infectious diseases driven by the expression of deleterious bacterial genes. Eligo ...
EG 427 has developed a unique, non-replicative Herpes Simplex Virus type 1 (nrHSV-1) based vector platform. It delivers, with pinpoint precision, highly selective, durable expression of disease modifying transgenes. We take advantage of it to design new treatments of peripheral nervous system ...
Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Astraveus's cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. The deep ...
Created in 2020 and based in Paris, STANDING OVATION aims to become a key player in the food transition. The company is developing the production of fermentative caseins and their transformation into non-animal, lactose-free substitutes for cheese and dairy products. Standing Ovation recently ...
At Inato, our mission is to bring clinical research to each and every patient, regardless of who they are and where they live. We are building the world's first clinical trial marketplace to create greater visibility, access, and engagement across a more diverse population of doctors and their ...
